Chiovato L, Martino E, Tonacchera M, Santini F, Lapi P, Mammoli C, Braverman L E, Pinchera A
Istituto di Endocrinologia, University of Pisa, Italy.
Endocrinology. 1994 May;134(5):2277-82. doi: 10.1210/endo.134.5.8156930.
Amiodarone, a potent antiarrhythmic drug, contains 37.2% iodine by weight and may induce either hypo- or hyperthyroidism. The high iodine content of amiodarone may be responsible for both complications, but a cytotoxic effect of the drug on the thyroid resulting in thyroiditis has been reported. In the present study the cytotoxic effect of amiodarone was evaluated in three culture systems with different biological properties: 1) a strain of rat thyroid cells (FRTL-5 cells) that maintains most differentiated functions of normal thyroid cells, including an active iodide pump, but an inability to organify iodide; 2) a line of Chinese hamster ovary (CHO) fibroblasts; and 3) freshly prepared primary cultures of human thyroid follicles (hTF) that trap and organify iodide. Cells were radiolabeled with 51Cr and incubated for 24 h with medium alone, medium plus amiodarone (3.75-200 microM), medium plus an iodinated radiographic contrast agent (sodium diatrizoate; 7.5-200 microM), or medium plus potassium iodide (7.5-300 microM). At concentrations ranging from 75-200 microM, amiodarone induced a significant and dose-dependent release of 51Cr in FRTL-5 cells. In contrast, diatrizoate or KI had no cytotoxic effect on FRTL-5 cells. In the same molar concentrations, amiodarone was also cytotoxic in CHO cells. In hTF, the release of 51Cr produced by amiodarone occurred at a lower concentration (37.5 vs. 75 microM) and was significantly greater than that in FRTL-5 cells. The cytotoxic effect of amiodarone in hTF was partially, but significantly, reduced by methimazole, an inhibitor of iodide organification. In the FRTL-5 cell culture system, amiodarone also produced a dramatic inhibition of TSH-stimulated cell growth. This growth-inhibiting effect of amiodarone was evident at low concentrations (3.75-7.5 mumol/liter) of the drug, which did not produce significant cytotoxicity. In conclusion, 1) amiodarone had a cytotoxic effect in CHO fibroblasts, a nonthyroid cell line; 2) this cytotoxic effect occurred in thyroid cells independent of their ability to organify iodide; 3) however, the toxic effect of amiodarone was greater and occurred at a lower molar concentration in freshly prepared human thyroid follicles that trap and organify iodide; and 4) in the latter culture system, methimazole, an inhibitor of iodide organification, partially, but significantly, reduced the cytotoxic effect of amiodarone. These data suggest that thyroid cytotoxicity produced by amiodarone is mainly due to a direct effect of the drug on thyroid cells, but excess iodide released from the drug may contribute to its toxic action.
胺碘酮是一种强效抗心律失常药物,按重量计含碘37.2%,可导致甲状腺功能减退或亢进。胺碘酮的高碘含量可能是这两种并发症的原因,但也有报道称该药物对甲状腺的细胞毒性作用会导致甲状腺炎。在本研究中,在三种具有不同生物学特性的培养系统中评估了胺碘酮的细胞毒性作用:1)一种大鼠甲状腺细胞系(FRTL - 5细胞),其维持正常甲状腺细胞的大多数分化功能,包括活跃的碘转运体,但无法将碘有机化;2)一株中国仓鼠卵巢(CHO)成纤维细胞系;3)新鲜制备的人甲状腺滤泡原代培养物(hTF),其能捕获并将碘有机化。用51Cr对细胞进行放射性标记,并分别在单独的培养基、加胺碘酮(3.75 - 200 microM)的培养基、加碘化造影剂(泛影酸钠;7.5 - 200 microM)的培养基或加碘化钾(7.5 - 300 microM)的培养基中孵育24小时。在75 - 200 microM浓度范围内,胺碘酮在FRTL - 5细胞中诱导了显著且剂量依赖性的51Cr释放。相比之下,泛影酸盐或KI对FRTL - 5细胞没有细胞毒性作用。在相同摩尔浓度下,胺碘酮对CHO细胞也具有细胞毒性。在hTF中,胺碘酮产生的51Cr释放发生在较低浓度(37.5对75 microM),且显著大于FRTL - 5细胞中的释放量。碘有机化抑制剂甲巯咪唑可部分但显著降低胺碘酮在hTF中的细胞毒性作用。在FRTL - 5细胞培养系统中,胺碘酮还显著抑制了促甲状腺激素刺激的细胞生长。胺碘酮的这种生长抑制作用在低浓度(3.75 - 7.5微摩尔/升)药物时就很明显,此时并未产生显著的细胞毒性。总之,1)胺碘酮对非甲状腺细胞系CHO成纤维细胞具有细胞毒性作用;2)这种细胞毒性作用在甲状腺细胞中发生,与它们将碘有机化的能力无关;3)然而,胺碘酮的毒性作用在能捕获并将碘有机化的新鲜制备的人甲状腺滤泡中更大且在较低摩尔浓度时就出现;4)在后者的培养系统中,碘有机化抑制剂甲巯咪唑可部分但显著降低胺碘酮的细胞毒性作用。这些数据表明,胺碘酮产生的甲状腺细胞毒性主要是由于该药物对甲状腺细胞的直接作用,但药物释放的过量碘可能有助于其毒性作用。